secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cencora, Inc. (COR)
CIK:        0001140859
Form:       8-K
Filed at:   2026-08-12T16:38:08+00:00
Accession:  0001104659-26-094676
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Cencora discloses Walgreens volume shift; reaffirms FY2026 EPS guidance
-----------------------------------------------------------------------

- Beginning July 1, 2026, certain Walgreens volume serviced outside the prime vendor agreement began moving away from Cencora.
- Prime vendor agreement unchanged and constitutes vast majority of Walgreens business.
- Volume shift fully contemplated in Aug 5, 2026 commentary on Q4 U.S. Healthcare Solutions expectations.
- Reaffirms FY2026 adjusted diluted EPS guidance of $17.75-$17.95.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1140859/000110465926094676/0001104659-26-094676-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1140859/000110465926094676/tm2622984d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-094676

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer